Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score
- PMID: 19006117
- PMCID: PMC6652971
- DOI: 10.1002/clc.20355
Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score
Abstract
Introduction: The purpose of this study was to assess the prevalence of emerging cardiac risk factors in individuals with a family history of premature coronary heart disease (CHD) and who were predicted to be low-risk for cardiovascular (CV) disease based on their Framingham risk score.
Methods: We prospectively evaluated 89 younger men and women with a family history of premature CHD and who had a low Framingham risk score. Patients with CHD or CHD equivalents were excluded. All patients were screened for emerging clinical and lipid risk factors.
Results: Coronary calcium was present in 38% of patients and C-reactive protein > 3 mg/dl was present in 24% of patients. Low levels of high-density lipoprotein (HDL2) cholesterol were the most prevalent emerging lipid risk factor and was present in 72% of the study group. More individuals had low levels of HDL2 than total HDL (34% versus 71%; p-value =0.001). Triglyceride- (TG)-rich remnant lipoproteins were present in 49% of patients.
Conclusions: The Framingham risk score poorly predicts CV risk in younger healthy persons with a family history of premature CHD. The prevalence of subclinical CHD and emerging clinical and lipid risk factors is high in these patients. The most prevalent lipid risk factor was low levels of HDL2. Individuals with a family history of premature CHD may benefit from screening for emerging risk factors to better assess their CV risk.
Copyright 2008 Wiley Periodicals, Inc.
References
-
- Grundy SM, Cleeman JI, Bairey Merz N, Brewer HB, Clark LT, et al: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood 2 : Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239. - PubMed
-
- Nasir K, Michos ED, Rumberger JA, Braunstein JB, Post WS, et al.: Coronary artery calcification and family history of premature coronary heart disease: Sibling history is more strongly associated than parental history. Circulation 2004; 110: 2150–2156. - PubMed
-
- Tonstad S, Westheim A: Implementation of guidelines to screen relatives of patients with premature coronary heart disease in a hospital setting. Am J Cardiology 2002; 90: 1211–1214. - PubMed
-
- Nasir K, Michos ED, Blumenthal RS, Raggi P: Detection of high risk young adults and women by coronary calcium and national cholesterol education program panel III guidelines. J Am Coll Cardiol 2005; 46: 1931–1936. - PubMed
-
- Genest JJ, Munley SS, McNamara JR, Ordovas JM, Jenner J, et al.: Familial lipoprotein disorders with premature coronary artery disease. Circulation 1992; 85: 2025–2033. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
